Pembrolizumab Improves Disease-Free Survival for Muscle-Invasive Urothelial Carcinoma
February 1st 2024The late-breaking data at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium included the results of KEYNOTE-123 for locally advanced resectable urothelial carcinoma.
Read More
Recurrent C difficile Infection Prevention: Efficacy and Administration of Fecal Microbiota Therapy
January 31st 2024Sharon Rimon, NP, shares insights on the rectal administration of fecal microbiota therapy, highlighting its efficacy, ease of adoption in clinical practice, and benefits for patients.
Read More
Give Your Patients Options for Managing Menstrual Pain
Recommendations range from contraceptives to heat therapy to holistic use of spices.
Read More
Pharmacy Focus Oncology: Advancements in Hematology and Breast Cancer - ASH and SABCS 2023 Recap
January 29th 2024Pharmacy Times provides a comprehensive recap of the latest advancements in hematology and breast cancer, shared at the 2023 American Society of Hematology and the San Antonio Breast Cancer Symposium conferences
Listen